About Carvostill 6.25 Tablet
Unlock a rarefied sense of well-being with Carvostill 6.25 Tablet-your immaculate solution for hypertension and heart failure. Grab this enlightened therapy available only for a limited time, exclusively via prescription. Each round, white to off-white tablet contains 6.25 mg of Carvedilol, carefully crafted by Healing Pharma India Pvt. Ltd. and approved by DCGI. Formulated for adults, Carvostill 6.25 is ideal for those seeking uncompromising cardiac care. Store below 30C and protect from light and moisture to preserve efficacy.
Immaculate Control for Cardiac Health
Carvostill 6.25 Tablet is an allopathic, oral antihypertensive and beta blocker specifically designed for adults with hypertension, heart failure, or left ventricular dysfunction following myocardial infarction. Its special features include a reliable carvedilol composition, convenient blister packaging, and stringent quality from Healing Pharma. Usage is simple: take orally with or without food as directed by your physician. Trust Carvostill 6.25 to support your heart health with every dose.
Delivery and Packaging Details for Optimal Outlay
FOB Port availability ensures seamless delivery and efficient drop-off, suitable for both domestic and export needs. Carvostill 6.25 Tablets arrive in blister packs-five strips per box, each containing 10 tablets-offering secure protection during transport. The sample policy is flexible, allowing prospective buyers to evaluate quality before a full outlay. Expect meticulous packaging designed to maintain tablet integrity from dispatch to final delivery.
FAQ's of Carvostill 6.25 Tablet:
Q: How should Carvostill 6.25 Tablet be taken for optimal results?
A: Carvostill 6.25 Tablet should be taken orally, with or without food, strictly as prescribed by your physician. Do not alter the dosage without medical advice.
Q: What are the main benefits of using Carvostill 6.25 Tablet?
A: Carvostill 6.25 helps manage hypertension, heart failure, and left ventricular dysfunction post-myocardial infarction, offering comprehensive cardiac protection under clinical supervision.
Q: Where is Carvostill 6.25 Tablet manufactured and approved?
A: This medicine is manufactured by Healing Pharma India Pvt. Ltd. in India and is approved by the Drug Controller General of India (DCGI).
Q: When should this medication not be used?
A: Carvostill 6.25 Tablet is contraindicated in individuals with asthma, severe hepatic impairment, or heart block. Always consult your physician before initiating therapy.
Q: What side effects may occur with Carvostill 6.25 Tablet?
A: Possible side effects include dizziness, fatigue, low blood pressure (hypotension), and slow heart rate (bradycardia). Contact your doctor if you experience any adverse symptoms.